Indeed, whereas both the KD of SOX12 and TMED3 are effective in CC14 (with undetermined APC status in this non-clonal primary colon cancer cell population), TMED3 KD has diminished potency in comparison with KD of SOX12 in HT29. The gene discussed is SOX12; the disease is malignant colon neoplasm.